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We report a case of a 64-year-old man who pre-
sented with liquefying panniculitis associated
with intraductal papillary mucinous neoplasm
(IPMN) after the Whipple operation.
Case report
A 64-year-old man presented with a weight loss of
10 kg over 1 year and insomnia. CT scan revealed
an approximate 3.0 cm homogeneous low-density
mass in the head of pancreas.
Tumor markers including CEA, CA125, AFP
and CA199 were not elevated. The patient’s
serum levels of amylase, lipase and calcium
were normal. The patient received the pancreato-
duodenectomy on 3 March 2010 and the post-
operative pathology gave a deﬁnite diagnosis of
IPMN of the pancreas (Figure 1).
0.1 mg of octreotide injected subcutaneously
every 8 h was postoperatively administered to
suppress pancreatic secretion and decrease the
risk of pancreatic ﬁstula. On postoperative day 2,
on the right lower limb skin a localized erythema
appeared which slowly became larger, but the
subcutaneous lesion did not bulge onto the
surface of the skin. Subsequently the localized
red-brown erythema was present over the right
upper leg and knee joint. On postoperative day
5, the examination showed multiple subcutaneous
inﬂammatory nodules on the legs and the buttock
(Figure 2).
Some of the larger lesions were necrotic and
exuded a viscous fatty material, accompanied by
general malaise. On postoperative day 7, we
invited the dermatologist to examine the patient
and made a diagnosis of liquefying panniculitis.
According to the report from the former literature,
the octreotide was effective to liquefying pannicu-
litis.
1,2 We increased octreotide intravenous infu-
sion to 0.6 mg every day and simultaneously
used the Medrol (glucocorticoid, 20 mg/24h),
2
Ulinastatin (protease inhibitors) and antibiotics.
No new nodules appeared and the original
nodules did not change. However, the patient
appeared anastomotic leakages and the wound
grew worse. Drainage pipes discharged some
yellow oily mucus substance. The patient had to
receive the second operation on 1 April 2010.
Introperatively, we found the pelvic cavity ﬁlled
with brown oily necrotic liquids of about 50 mL.
The postoperative pathology showed the necrosis
of omental fat tissue. Unfortunately, several days
later, new erythemas spread and scattered over
his right thigh and right hand wrist. The former
nodules grew larger again. The patient died of
multiple organ failure on 27 April 2010.
Discussion
Panniculitis has rarely been reported in the world
since the ﬁrst report of Weber in 1935.
1–6 Most of
them were associated with pancreatitis or pancrea-
tic carcinomas and had poor prognosis.
1–5In 2006,
Gahr et al. presented the ﬁrst case of intraductal
papillary mucinous adenoma of the pancreas
associated with lobular panniculitis.
7 Hereon, we
presented a case of liquefying panniculitis associ-
ated with IPMN. Liquefying panniculitis (Roth-
man’s panniculitis) is a special type of nodular
panniculitis (Weber-Christian disease).
6 In the
past 20 years, one case of liquefying panniculitis
has been reported in China.
2 Compared with
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1domestic cases, there are more foreign cases
reported. Most of them associated with pancreatic
diseases have poor prognosis. In our case, the
retinal tissue is involved
8 and anastomotic lea-
kages appear which lead to a fatal outcome. The
pathogenesis of pancreatic panniculitis is still
unknown. The pancreatic enzymes, such as
trypsin, may increase the permeability of the
microcirculation and are involved in the process
of fat degradation, which produces more free
fatty acids combining with calcium to form
soap.
5 However, cases of fat necrosis with
normal serum lipase levels have also been
described.
6 These reports suggest that there must
be some other factors which allow the pancreatic
enzymes to escape from the circulation and act
on the subcutaneous fat. Deﬁciency of the
alpha-1-antitrypsin (AAT) was also mentioned as
a cause of pancreatic panniculitis.
9 According to
the literature, octreotide and methylprednisolone
can only slow down the progress of the
disease.
1,2 The patient’s only preoperative
symptom is the insomnia which has developed
on him for many years,
10 so the study on
whether the insomnia is associated with liquefy-
ing panniculitis becomes crucial, which may
offerevidence for the early diagnosis of the panni-
culitis. In this case, skin lesions appeared post-
operative and the operation may also be a
predisposing risky factor for liquefying panniculi-
tis and the exact mechanism needs to be further
explored.
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The photograph showing a large area of the skin
lesions on the right lower limber leg and knee
joint, respectively
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